Additionally, short‐chain FOS reduce body lipid accumulation, visceral adiposity, and insulin resistance in diet‐induced obesity models and overweight subjects by remodeling the gut microbiota and improving metabolic profiles (Ding et al. 2025; Yoo et al. 2024; Yu et al. 2019). This evidence concerns the gene FOS and Obesity.